142 related articles for article (PubMed ID: 37355441)
1. Survey on the usage of therapeutic erythrocytapheresis in transfusion services in Italy for the treatment of polycythemia vera, secondary erythrocytosis and hemochromatosis.
Iuliani O; Passeri C; Inghilleri G; Di Bartolomeo E; Abbruzzese L; Bianco I; Foddai ML; Natale GA; De Fusco G; D'Onofrio M; Fadda MG; Dominijanni A; Savignano C; Ostuni A
Transfus Apher Sci; 2023 Oct; 62(5):103752. PubMed ID: 37355441
[TBL] [Abstract][Full Text] [Related]
2. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.
Evers D; Kerkhoffs JL; Van Egmond L; Schipperus MR; Wijermans PW
J Clin Apher; 2014 Jun; 29(3):133-8. PubMed ID: 24130064
[TBL] [Abstract][Full Text] [Related]
3. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit: an evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosis.
Evers D; Kerkhoffs JL; Van Egmond L; Wijermans PW
Transfus Apher Sci; 2013 Apr; 48(2):187. PubMed ID: 23809828
[No Abstract] [Full Text] [Related]
4. Therapeutic erythroapheresis: Experience in patients with polycythemia vera and secondary erythrocytosis.
Parra Salinas I; Recasens Flores V; Montañés MÁ; García-Erce JA
Med Clin (Barc); 2020 Jan; 154(1):16-19. PubMed ID: 30795904
[TBL] [Abstract][Full Text] [Related]
5. Erythrocytapheresis versus phlebotomy in the maintenance treatment of HFE hemochromatosis patients: results from a randomized crossover trial.
Rombout-Sestrienkova E; Winkens B; Essers BA; Nieman FH; Noord PA; Janssen MC; van Deursen CT; Boonen A; Reuser-Kaasenbrood EP; Heeremans J; van Kraaij M; Masclee A; Koek GH
Transfusion; 2016 Jan; 56(1):261-70. PubMed ID: 26358375
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic erythrocytapheresis: technical aspects and clinical applications].
Poullin P; Lefèvre P
Rev Med Interne; 2008 Apr; 29(4):290-6. PubMed ID: 18280010
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of therapeutic erythrocytapheresis (TEA).
Valbonesi M; Bruni R
Transfus Sci; 2000 Jun; 22(3):183-94. PubMed ID: 10831921
[TBL] [Abstract][Full Text] [Related]
8. Course of iron parameters in HFE-hemochromatosis patients during initial treatment with erythrocytapheresis compared to phlebotomy.
Rombout-Sestrienkova E; Koek GH; Neslo R; van Kraaij M; Menheere PP; Masclee A; Swinkels DW
J Clin Apher; 2016 Dec; 31(6):564-570. PubMed ID: 26878994
[TBL] [Abstract][Full Text] [Related]
9. [Erythrocytapheresis in patients with secondary polyglobulia].
Kessler P
Vnitr Lek; 2004 Sep; 50(9):682-4. PubMed ID: 15580902
[TBL] [Abstract][Full Text] [Related]
10. Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial.
Rombout-Sestrienkova E; Nieman FH; Essers BA; van Noord PA; Janssen MC; van Deursen CT; Bos LP; Rombout F; van den Braak R; de Leeuw PW; Koek GH
Transfusion; 2012 Mar; 52(3):470-7. PubMed ID: 21848963
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the results obtained with traditional phlebotomy and with therapeutic erythrocytapheresis in patients with erythrocytosis.
Vecchio S; Leonardo P; Musuraca V; D'Ettoris AR; Geremicca W
Blood Transfus; 2007 Jan; 5(1):20-3. PubMed ID: 19204747
[TBL] [Abstract][Full Text] [Related]
12. [Blood rheologic disorders in patients with polycythemia vera and their correction by therapeutic erythrocytapheresis].
Likhovetskaia ZM; Prigozhina TA; Gorbunova NA; Kalinin NN; Petrov MM
Gematol Transfuziol; 1989 Nov; 34(11):33-6. PubMed ID: 2612862
[TBL] [Abstract][Full Text] [Related]
13. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns.
Streiff MB; Smith B; Spivak JL
Blood; 2002 Feb; 99(4):1144-9. PubMed ID: 11830459
[TBL] [Abstract][Full Text] [Related]
14. Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis?
Teofili L; Valentini CG; Rossi E; De Stefano V
Leukemia; 2019 Jan; 33(1):279-281. PubMed ID: 30518810
[No Abstract] [Full Text] [Related]
15. Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis.
Sundic T; Hervig T; Hannisdal S; Assmus J; Ulvik RJ; Olaussen RW; Berentsen S
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s84-9. PubMed ID: 24333062
[TBL] [Abstract][Full Text] [Related]
16. Who needs a therapeutic phlebotomy?
Antle EA
Clin J Oncol Nurs; 2010 Dec; 14(6):694-6. PubMed ID: 21112847
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the influence of body weight index to the result of therapeutic erythrocytapheresis in patients with polycythemia vera.
Bai J; Zhang L; Hu X; Xue Y; Long F; Zhang B; Yan S
Transfus Apher Sci; 2012 Dec; 47(3):295-9. PubMed ID: 22990001
[TBL] [Abstract][Full Text] [Related]
18. The Italian registry of therapeutic apheresis in SISTRA: Year of activity 2022.
De Silvestro G; Catalano L; Marano G; Piccinini V; Pupella S; Ostuni A; De Angelis V
Transfus Apher Sci; 2024 Feb; 63(1):103863. PubMed ID: 38065773
[TBL] [Abstract][Full Text] [Related]
19. [Erythron in patients with polycythemia vera during treatment by erythrocytapheresis and bloodletting].
Gudim VI; Sarycheva TG; Kotel'nikov VM; Melikian AL; Ivanova VS
Ter Arkh; 1987; 59(6):48-51. PubMed ID: 3629498
[TBL] [Abstract][Full Text] [Related]
20. The Italian Register of therapeutic apheresis: How it has grown, how it has changed.
De Silvestro G; Tison T; Colpo A; Marson P;
Transfus Apher Sci; 2019 Jun; 58(3):281-286. PubMed ID: 31047825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
